Low-dose HRT skin patches ’safer than tablets’
June 4th, 2010 - 1:26 pm ICT by ANILondon, June 4 (ANI): A new study by researchers in Canada and Germany suggests that hormone replacement therapy (HRT) skin patches containing low doses of oestrogen carry less risk of stroke than oral therapy and may represent a safer alternative to tablets.
However, the risk increases significantly with high dose patches.
HRT is regularly prescribed to women suffering from the effects of the menopause. However, most studies have shown an increased risk of stroke associated with taking HRT. There is also evidence that different routes of administering HRT may be associated with a different risk of cerebrovascular events.
So, researchers of the new study assessed the risk of stroke associated with oral and transdermal (through the skin) HRT in post-menopausal women in the UK.
Their findings are based on data from the General Practice Research Database (GPRD), which holds the anonymised medical records of millions of patients registered with family doctors across the UK.
From a population of over 870,000 women aged 50-79 between January 1987 and October 2006, they identified 15,710 cases with a first recorded diagnosis of stroke occurring in the study period. Each case was matched to 59,958 controls.
Exposure to HRT was categorised into oestrogens only, oestrogens plus progestogen, progestogen only, and tibolone. Oestrogens were further subdivided according to the route of administration (oral or transdermal) and to the dose (high or low).
The risk of stroke was not increased with use of low oestrogen dose patches compared with no use, whereas the risk was increased by up to 88 percent with high dose patches.
Use of oral HRT increased the rate of stroke by around 25-30 percent compared with no use, regardless of the oestrogen dose or when combined with progestogen.
There was no risk increase with short-term use (less than one year) of the oral formulations, but longer-term users (more than one year) of the oral agents had a 35 percent increased risk.
The study has been published on bmj.com. (ANI)
- Hormone replacement therapy tied to breast cancer - Dec 30, 2011
- Hormone replacement therapy may worsen incontinence in postmenopausal women - Oct 07, 2009
- Some pills more likely to cause blood clots - Oct 26, 2011
- Oestrogen-only HRT 'raises asthma risk after menopause' - Feb 08, 2010
- Hormone replacement therapy increases breast cancer risk - Aug 12, 2010
- Hormone-replacement therapy 'ups risk of dying from lung cancer' - Sep 20, 2009
- Side effects that are actually beneficial for you - Dec 15, 2010
- Withdrawing HRT from women cuts breast cancer risk, shows study - Sep 24, 2010
- 3 drugs found to reduce breast cancer risk, have distinct side effects - Sep 16, 2009
- Stopping hormone replacement cuts breast cancer risk - Sep 24, 2010
- Oestrogen patch for sharper memory? - Jan 25, 2011
- Contraceptive gel may replace pills - Oct 26, 2010
- Non oral contraceptives carry higher clot risks - May 11, 2012
- Age, method of HRT governs quantum of women''s heart-attack risk - Oct 01, 2008
- New scientific statement weighs pros and cons of menopausal hormone therapy - Jun 23, 2010
Tags: cerebrovascular events, diagnosis, dose hrt, family doctors, hormone replacement therapy, medical records, menopausal women, menopause, oestrogen dose, oestrogens, oral agents, oral hrt, oral therapy, population, progestogen, research database, skin patches, stroke, study period, term users